Literature DB >> 20630914

Chemotherapy-induced myelotoxicity and incidence of lung metastasis in an animal model.

Jin-Young Son1, Jang-Woo Shin, Jing-Hua Wang, Hye-Jung Park, Hyeong-Geug Kim, Hanumantha Rao Balaji Raghavendran, Chang-Gue Son.   

Abstract

We examined how chemotherapy-induced myelotoxicity and the associated leukopaenia affect cancer metastasis in an animal model. Myelotoxicity was induced by a single injection of 5-fluorouracil (5-FU) or Cisplatin, administered to 7-week-old BALB/c mice. CT-26 murine colon carcinoma cells were injected into the lateral tail vein on days 0, 1, 3, 5, and 7 after anticancer drug injection. On day 14 after cancer cell injection, the number of pulmonary colonies was measured in a double-blind setting. Compared with Cisplatin, 5-FU induced severe leukopaenia and bone marrow suppression, while on day 5, both drugs induced severe myelotoxicity. The number of pulmonary colonies did not correlate with the severity of leukopaenia, regardless of the type or time of drug injection, except in the group pretreated with Cisplatin (3 days prior to cancer cell injection). Our results suggest that chemotherapy-induced myelotoxicity does not increase the incidence of cancer metastasis in this animal model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20630914     DOI: 10.1177/0960327110377521

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  5 in total

Review 1.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

2.  High-dose ionizing radiation-induced hematotoxicity and metastasis in mice model.

Authors:  Jang Woo Shin; Jin Young Son; Hanumantha Rao Balaji Raghavendran; Weon Kyu Chung; Hyeong Geug Kim; Hye Jung Park; Seong Soon Jang; Chang Gue Son
Journal:  Clin Exp Metastasis       Date:  2011-07-19       Impact factor: 5.150

3.  Divergent effects of AKI to CKD models on inflammation and fibrosis.

Authors:  L M Black; J M Lever; A M Traylor; B Chen; Z Yang; S K Esman; Y Jiang; G R Cutter; R Boddu; J F George; A Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-13

4.  Antiemetic and Myeloprotective Effects of Rhus verniciflua Stoke in a Cisplatin-Induced Rat Model.

Authors:  Hyo-Seon Kim; Hyeong-Geug Kim; Hwi-Jin Im; Jin-Seok Lee; Sung-Bae Lee; Won-Yong Kim; Hye-Won Lee; Sam-Keun Lee; Chang Kyu Byun; Chang-Gue Son
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-08       Impact factor: 2.629

5.  Adverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study.

Authors:  Marília Berlofa Visacri; Eder de Carvalho Pincinato; Graziele Baldan Ferrari; Júlia Coelho França Quintanilha; Priscila Gava Mazzola; Carmen Silvia Passos Lima; Patricia Moriel
Journal:  Daru       Date:  2017-04-24       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.